Hi Tamz, it has been a reasonable end to the year, the S/P has...

Hi Tamz, it has been a reasonable end to the year, the S/P has regained to finish where we were when the F/Y results were released. Time to get over the IDX attempt, although interested in the cost involved.
The recent acquisitions should be earning positive from what I hear, a improved earnings = higher S/P. Enlitic is certainly in lots of road showing, all part of the process in getting recognition and moving forward, a FDA approval hopefully sometime in the near future. I would like to review there accounts to better understand there current position.
I can see the the S/P improving this year, based on improved earnings, and no changes to regulations due to upcoming election, health is one of Australia’s major debates that will decide the outcome.
FJ do you have any news to share?
All the best for the F/Y ahead everyone.

Champee